A common acid reflux medication taken by 15 per cent of the UK population could be contributing to a rise in scurvy cases, ...

AN ancient disease has been making a comeback and it could be caused by an acid reflux drug, a new study has warned. Health ...

Writing in the journal British Medical Journal Case Reports, doctors at the Sir Charles Gairdner Hospital in Western ...

Proton pump inhibitors (PPIs) are widely used medications to manage common digestive issues like heartburn, acid reflux, and ...

Most stomach polyps are asymptomatic, meaning people do not know they have them until they have an endoscopy. Learn what is ...

Phathom is in the final stages of obtaining FDA feedback on the Phase 2 study and program investigating VOQUEZNA as a potential treatment for Eosinophilic Esophagitis (EoE) in adults and adolescents, ...

There is no significant association between the use of proton pump inhibitors (PPIs) and risk for cardiovascular events, a meta-analysis shows. However, patients with gastroesophageal reflux disease ...

Additionally, Renexxion has received FDA IND clearance for naronapride as a potential treatment for proton pump inhibitor non-responsive symptomatic gastroesophageal reflux disease (PPI-nrsGERD).

A few studies have found an association between microscopic colitis and proton-pump inhibitor (PPI). The aim of our study was to evaluate the risk of developing microscopic colitis and its subtypes ...

Today is a big day for Proton as the company has finally unveiled one of the most important details for Proton e.MAS 7: pricing. While today’s announcement does not involve the final price tag for the ...